Analyst Price Targets — INMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 7, 2026 9:32 am | — | Barclays | $19.00 | $13.59 | TheFly | InMode price target lowered to $19 from $21 at Barclays |
| February 11, 2026 12:03 pm | Jeff Johnson | Robert W. Baird | $17.00 | $14.62 | TheFly | InMode price target raised to $17 from $16 at Baird |
| December 17, 2025 12:15 pm | — | Canaccord Genuity | $15.00 | $14.48 | TheFly | InMode price target lowered to $15 from $16 at Canaccord |
| April 14, 2025 5:13 pm | Matthew Taylor | Jefferies | $15.00 | $15.08 | TheFly | InMode price target lowered to $15 from $16 at Jefferies |
| October 16, 2024 4:06 pm | Sam Elber | BTIG | $25.00 | $16.88 | StreetInsider | BTIG Starts InMode Ltd. (INMD) at Buy |
| October 12, 2024 5:23 pm | Matt Miksic | Barclays | $27.00 | $16.50 | TheFly | InMode price target lowered to $27 from $29 at Barclays |
| July 23, 2024 5:00 am | Matthew Taylor | Jefferies | $19.00 | $17.75 | TheFly | InMode downgraded to Hold from Buy at Jefferies |
| July 12, 2024 6:30 am | Caitlin Cronin | Canaccord Genuity | $16.00 | $16.82 | TheFly | InMode price target lowered to $16 from $21 at Canaccord |
| May 3, 2024 7:06 am | Danielle Antalffy | UBS | $20.00 | $17.36 | StreetInsider | InMode Ltd. (INMD) PT Lowered to $20 at UBS |
| October 13, 2023 2:11 pm | Caitlin Cronin | Canaccord Genuity | $22.00 | $20.75 | Benzinga | InMode Faces Revenue Headwinds Amid Challenging Economics: Analyst Cuts Price Target And Estimates |
Latest News for INMD
InMode Ltd. (NASDAQ: INMD - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $14.26 and traded as high as $15.20. InMode shares last traded at $15.03, with a volume of 799,933 shares changing hands. Analyst Ratings
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture P
YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter of 2026.
NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (together with its affiliates, “Steel”), a significant, long-standing shareholder of InMode Ltd. (“InMode” or the “Company”) (Nasdaq: INMD), today issued a letter to InMode shareholders urging them to vote AGAINST Proposal 1 and AGAINST Proposal 4 at the Company's July 30, 2026 Annual General Meeting. The full text of the letter is below. July 28, 2026 Dear…
NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (together with its affiliates, “Steel”), a significant, long-standing shareholder of InMode Ltd. (“InMode” or the “Company”) (Nasdaq: INMD), today issued a letter to the Board of Directors (the “Board”) of the Company. The full text of the letter is below. July 16, 2026 VIA ELECTRONIC MAIL InMode Ltd. Tavor Building, Sha'ar Yokneam P.O. Box 533 Yokneam 2069206…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for INMD.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.